Fig. 5From: Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcomaDevelopment and evaluation of nomograms for predicting osteosarcoma survival and lung metastasis. Nomograms for predicting the 3-, 5-, and 10-year overall survival (A) and lung metastasis-free survival (B) of patients with osteosarcoma. Calibration plots (C, D) and decision curve analysis (E, F) of these two proposed nomograms in both the training and validation sets.Back to article page